Dow Jones

40,003.59

0.34%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

CDMO

Avid Bioservices (CDMO)

Avid Bioservices Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CDMO

1 2 3 4 5 6 7 8 9 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
07/05/2024	15:05	GlobeNewswire Inc.	Avid Bioservices to Participate at Upcoming Investor Conferences	NASDAQ:CDMO	Avid Bioservices Inc
24/04/2024	16:25	GlobeNewswire Inc.	Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024	NASDAQ:CDMO	Avid Bioservices Inc
20/03/2024	06:00	GlobeNewswire Inc.	Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q	NASDAQ:CDMO	Avid Bioservices Inc
07/03/2024	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDMO	Avid Bioservices Inc
06/03/2024	22:58	GlobeNewswire Inc.	Avid Bioservices Announces Pricing of Private Placement of Convertible Notes	NASDAQ:CDMO	Avid Bioservices Inc
06/03/2024	15:32	GlobeNewswire Inc.	Avid Bioservices Announces Proposed Private Placement of Convertible Notes	NASDAQ:CDMO	Avid Bioservices Inc
06/03/2024	15:31	GlobeNewswire Inc.	Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024	NASDAQ:CDMO	Avid Bioservices Inc
26/01/2024	15:57	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CDMO	Avid Bioservices Inc
12/01/2024	18:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CDMO	Avid Bioservices Inc
19/12/2023	15:05	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:CDMO	Avid Bioservices Inc
07/12/2023	15:48	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CDMO	Avid Bioservices Inc
07/12/2023	15:05	GlobeNewswire Inc.	Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023	NASDAQ:CDMO	Avid Bioservices Inc
01/12/2023	17:16	PR Newswire (US)	Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600	NASDAQ:CDMO	Avid Bioservices Inc
30/11/2023	15:05	GlobeNewswire Inc.	Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023	NASDAQ:CDMO	Avid Bioservices Inc
17/11/2023	15:35	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:CDMO	Avid Bioservices Inc
08/11/2023	07:05	GlobeNewswire Inc.	Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs	NASDAQ:CDMO	Avid Bioservices Inc
17/10/2023	07:05	GlobeNewswire Inc.	Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility	NASDAQ:CDMO	Avid Bioservices Inc
10/10/2023	20:19	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CDMO	Avid Bioservices Inc
26/09/2023	15:05	GlobeNewswire Inc.	Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference	NASDAQ:CDMO	Avid Bioservices Inc
07/09/2023	16:00	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:CDMO	Avid Bioservices Inc
07/09/2023	15:05	GlobeNewswire Inc.	Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2023	NASDAQ:CDMO	Avid Bioservices Inc
31/08/2023	15:05	GlobeNewswire Inc.	Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2024 After Market Close on September 7, 2023	NASDAQ:CDMO	Avid Bioservices Inc
28/08/2023	15:59	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:CDMO	Avid Bioservices Inc
28/08/2023	15:58	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:CDMO	Avid Bioservices Inc
21/06/2023	16:01	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:CDMO	Avid Bioservices Inc
21/06/2023	15:47	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CDMO	Avid Bioservices Inc
21/06/2023	15:07	GlobeNewswire Inc.	Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2023	NASDAQ:CDMO	Avid Bioservices Inc
14/06/2023	15:05	GlobeNewswire Inc.	Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2023 After Market Close on June 21, 2023	NASDAQ:CDMO	Avid Bioservices Inc
08/06/2023	18:46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CDMO	Avid Bioservices Inc
10/05/2023	15:05	GlobeNewswire Inc.	Avid Bioservices to Participate in RBC Capital Markets Global Healthcare Conference	NASDAQ:CDMO	Avid Bioservices Inc